Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
9
|
| pubmed:dateCreated |
1982-2-12
|
| pubmed:abstractText |
The essential prolongation of the survival time of the patients with advanced renal carcinoma after the combined therapy by more than the threefold shows in comparison to the symptomatically treated patients that in these cases the nephrectomy with subsequent cytostatic therapy is indicated.
|
| pubmed:language |
ger
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Sep
|
| pubmed:issn |
0044-3611
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
74
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
667-9
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading | |
| pubmed:year |
1981
|
| pubmed:articleTitle |
[Treatment of advanced kidney cancer].
|
| pubmed:publicationType |
Journal Article,
English Abstract
|